These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2119485)

  • 21. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost comparison of in-center dialysis, home dialysis, and transplantation in the Nashville area.
    Thompson K
    Nephrol Nurse; 1980; 2(6):23-4. PubMed ID: 7003421
    [No Abstract]   [Full Text] [Related]  

  • 23. A break-even point in the ESRD program.
    Mayer RL
    Nephrol News Issues; 1989 Nov; 3(11):20-1. PubMed ID: 2594106
    [No Abstract]   [Full Text] [Related]  

  • 24. [Regular dialysis and kidney transplantation as complementary methods of treatment--medical and economic aspects].
    Zec J; Orlić P; Vujaklija-Stipanović K; Razmilić D; Valencić M; Cohar F; Grzetić M; Matić-Glazar D
    Lijec Vjesn; 1987; 109(11-12):458-60. PubMed ID: 3320650
    [No Abstract]   [Full Text] [Related]  

  • 25. Squeezing the inner-city dialysis dollar.
    Kanter A
    Nephrol News Issues; 1989 Nov; 3(11):24-6. PubMed ID: 2594108
    [No Abstract]   [Full Text] [Related]  

  • 26. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
    Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
    Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dialysis versus renal transplantation; a comparative study on medical cost and quality of life in patients with chronic renal failure].
    Tajima A; Ueda D; Hirai M; Morinaga S; Sudoko H; Yamaguchi Y; Mitsuhashi T; Nakano M; Kanbayashi T; Ushiyama T
    Hinyokika Kiyo; 1987 Oct; 33(10):1536-41. PubMed ID: 3128069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematocrit battle puts patients on the losing end.
    Neumann ME
    Nephrol News Issues; 1991 Mar; 5(3):5, 48, 57. PubMed ID: 1961276
    [No Abstract]   [Full Text] [Related]  

  • 29. Can end-stage renal disease be delayed?
    Naper J
    Hosp Technol Ser; 1994 Dec; 13(15):5-7. PubMed ID: 10139506
    [No Abstract]   [Full Text] [Related]  

  • 30. Sadler sees hope in new rehabilitation efforts.
    Sadler JH
    Nephrol News Issues; 1994 Mar; 8(3):11, 44-5. PubMed ID: 7969535
    [No Abstract]   [Full Text] [Related]  

  • 31. Important cost differences of blood transfusions and erythropoietin between hemodialysis and peritoneal dialysis patients.
    Pagé DE; House A
    Adv Perit Dial; 1998; 14():87-9. PubMed ID: 10649699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan.
    Furumatsu Y; Nagasawa Y; Hamano T; Iwatani H; Iio K; Shoji T; Ito T; Tsubakihara Y; Imai E
    Nephrol Dial Transplant; 2008 Mar; 23(3):984-90. PubMed ID: 17956890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ESRD data system needs a fix. Lack of updates impacts beneficiaries, costs Medicare; USRDS looks elsewhere for accurate data.
    Nephrol News Issues; 2002 Apr; 16(5):8, 10. PubMed ID: 11962159
    [No Abstract]   [Full Text] [Related]  

  • 34. [Readers' letters concerning F. Keller et al: "Financial incentives and dialysis"].
    Dehnert HG
    Med Klin (Munich); 2008 Jan; 103(1):47-8; author reply 51. PubMed ID: 18338429
    [No Abstract]   [Full Text] [Related]  

  • 35. Pre-emptive renal transplantation.
    Hakim NS; Benedetti E; Payne WD; Gruessner R; Gores P; Sutherland DE; Najarian JS; Matas AJ
    Int Surg; 1998; 83(4):330-2. PubMed ID: 10096754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The economics of dialyzer reuse in ESRD.
    Sullivan JD
    Nephrol News Issues; 2002 Apr; 16(5):32-4, 36, 38. PubMed ID: 11962149
    [No Abstract]   [Full Text] [Related]  

  • 37. Transplant and dialysis: the cost/benefit question.
    Blommers TJ; Schanbacher B; Corry RJ
    Iowa Med; 1984 Jan; 74(1):15-7. PubMed ID: 6423564
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost functions for dialysis facilities and the quality of dialysis.
    Escarce JJ; Feldman HI
    Health Serv Res; 1999 Feb; 33(6):1563-6. PubMed ID: 10029497
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of anemia in chronic renal failure (predialysis)].
    Ruedin P
    Praxis (Bern 1994); 1999 Jan; 88(5):173-7. PubMed ID: 10067374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dialysis strategy: cost and effectiveness.
    Kerr DN
    Proc Eur Dial Transplant Assoc; 1981; 18():664-73. PubMed ID: 6799954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.